FAK is one of the major regulators of the tumor microenvironment, and its inhibition helps overcome tumor fibrotic and immunosuppressive microenvironments [15], suggesting that FAK inhibition may be used to increase the tumor infiltration of CTLs. The gene discussed is PTK2; the disease is neoplasm.